A PCR amplicon-based SARS-CoV-2 replicon for antiviral screening
Tomohiro Kotaki; Xuping Xie; Pei-Yong Shi; Masanori Kameoka.
Preprint en Inglés | PREPRINT-BIORXIV | ID: ppbiorxiv-267567
Documentos relacionados
A PCR amplicon-based SARS-CoV-2 replicon for antiviral evaluation.
The Life of SARS-CoV-2 Inside Cells: Replication-Transcription Complex Assembly and Function.
A trans-complementation system for SARS-CoV-2 recapitulates authentic viral replication without virulence.
Identification of a 1.4-kb-Long Sequence Located in the nsp12 and nsp13 Coding Regions of SARS-CoV-2 Genomic RNA That Mediates Efficient Viral RNA Packaging.
Stable Cell Clones Harboring Self-Replicating SARS-CoV-2 RNAs for Drug Screen.
A novel cell culture system modeling the SARS-CoV-2 life cycle.
Precise Detection of Viral RNA by Programming Multiplex Rolling Circle Amplification and Strand Displacement.
An in silico scientific basis for LL-37 as a therapeutic for Covid-19.
Structures and functions of coronavirus replication-transcription complexes and their relevance for SARS-CoV-2 drug design.
Favipiravir for Treatment of Outpatients With Asymptomatic or Uncomplicated Coronavirus Disease 2019: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial.